Hereditary complement factor I deficiency. 1994

T J Vyse, and P J Späth, and K A Davies, and B J Morley, and P Philippe, and P Athanassiou, and C M Giles, and M J Walport
Rheumatology Unit, RPMS, Hammersmith Hospital, London, UK.

We describe four cases (from three families) of hereditary factor I deficiency, bringing the total number of cases now reported to 23. In one family there are two affected siblings: one has suffered recurrent pyogenic infections; the other is asymptomatic. In the second family, the patient had recurrent pyogenic infections and a self-limiting vasculitic illness; in the third family, the patient suffered recurrent pyogenic and neisserial infections. All four patients had markedly reduced concentrations of C3 in the serum (family 1 propositus: 28%; family 1 asymptomatic sibling: 15%; family 2: 31%; and family 3: 31% normal human serum) which was in the form of C3b. Low IgG2 levels may occur in primary C3 deficiency, and a reduction in IgG2 concentration to 1.14 g/l (normal: 1.30-5.90 g/l) was found in the patient from family 2. Using radioligand binding assays, we demonstrated increased binding of C3b to erythrocytes in a patient with factor I deficiency. This C3b could not be cleaved by autologous serum but could be cleaved by normal serum or purified factor I. We review and compare the published cases of C3, factor H and factor I deficiency.

UI MeSH Term Description Entries
D008297 Male Males
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D005192 Family Health The health status of the family as a unit including the impact of the health of one member of the family on the family as a unit and on individual family members; also, the impact of family organization or disorganization on the health status of its members. Health, Family
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D013290 Streptococcal Infections Infections with bacteria of the genus STREPTOCOCCUS. Group A Strep Infection,Group A Streptococcal Infection,Group A Streptococcal Infections,Group B Strep Infection,Group B Streptococcal Infection,Group B Streptococcal Infections,Infections, Streptococcal,Infection, Streptococcal,Streptococcal Infection

Related Publications

T J Vyse, and P J Späth, and K A Davies, and B J Morley, and P Philippe, and P Athanassiou, and C M Giles, and M J Walport
February 1996, The Journal of clinical investigation,
T J Vyse, and P J Späth, and K A Davies, and B J Morley, and P Philippe, and P Athanassiou, and C M Giles, and M J Walport
June 1986, Scandinavian journal of immunology,
T J Vyse, and P J Späth, and K A Davies, and B J Morley, and P Philippe, and P Athanassiou, and C M Giles, and M J Walport
April 1990, Presse medicale (Paris, France : 1983),
T J Vyse, and P J Späth, and K A Davies, and B J Morley, and P Philippe, and P Athanassiou, and C M Giles, and M J Walport
June 1993, Archives of internal medicine,
T J Vyse, and P J Späth, and K A Davies, and B J Morley, and P Philippe, and P Athanassiou, and C M Giles, and M J Walport
February 2003, Clinical and experimental immunology,
T J Vyse, and P J Späth, and K A Davies, and B J Morley, and P Philippe, and P Athanassiou, and C M Giles, and M J Walport
February 1988, Harefuah,
T J Vyse, and P J Späth, and K A Davies, and B J Morley, and P Philippe, and P Athanassiou, and C M Giles, and M J Walport
January 1975, The American journal of medicine,
T J Vyse, and P J Späth, and K A Davies, and B J Morley, and P Philippe, and P Athanassiou, and C M Giles, and M J Walport
July 1997, Immunology,
T J Vyse, and P J Späth, and K A Davies, and B J Morley, and P Philippe, and P Athanassiou, and C M Giles, and M J Walport
June 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation,
T J Vyse, and P J Späth, and K A Davies, and B J Morley, and P Philippe, and P Athanassiou, and C M Giles, and M J Walport
August 2000, Clinical immunology (Orlando, Fla.),
Copied contents to your clipboard!